Mihael H. Polymeropoulos
2009
In 2009, Mihael H. Polymeropoulos earned a total compensation of $4.1M as President and Chief Executive Officer at Vanda Pharmaceuticals, a 191% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $530,400 |
|---|---|
| Option Awards | $3,150,785 |
| Salary | $442,645 |
| Other | $7,350 |
| Total | $4,131,180 |
Polymeropoulos received $3.2M in option awards, accounting for 76% of the total pay in 2009.
Polymeropoulos also received $530.4K in non-equity incentive plan, $442.6K in salary and $7.4K in other compensation.
Rankings
In 2009, Mihael H. Polymeropoulos' compensation ranked 976th out of 9,885 executives tracked by ExecPay. In other words, Polymeropoulos earned more than 90.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 976 out of 9,885 | 90th |
Division Manufacturing | 335 out of 3,690 | 91st |
Major group Chemicals And Allied Products | 78 out of 866 | 91st |
Industry group Drugs | 51 out of 638 | 92nd |
Industry Pharmaceutical Preparations | 44 out of 446 | 90th |
Source: SEC filing on April 28, 2011.
Polymeropoulos' colleagues
We found five more compensation records of executives who worked with Mihael H. Polymeropoulos at Vanda Pharmaceuticals in 2009.
2009
John Feeney
Vanda Pharmaceuticals
Chief Medical Officer
2009
William Clark
Vanda Pharmaceuticals
Secretary
2009
Stephanie Irish
Vanda Pharmaceuticals
Chief Financial Officer
2009
Steven Shallcross
Vanda Pharmaceuticals
Chief Financial Officer
2009
Paolo Baroldi
Vanda Pharmaceuticals